Project Grant R01AI196333
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $627,462 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 7, 2025, with a completion date of July 31, 2030. The award supports basic immunological research investigating T cell exhaustion mechanisms in response to chronic viral infection, with a focus on understanding how...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $156,160 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 1, 2025, through August 31, 2027. This two-year career development award supports independent structural biology research focused on elucidating the molecular basis of Human Immunodeficiency Virus-1 (HIV-1)...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $200,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 4, 2025, with completion targeted for August 31, 2027. The grant funds research focused on identifying and validating microRNAs (miRNAs) that regulate neutrophil transendothelial migration (TEM) in gut...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $1,505,785 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 3, 2025, with completion by August 31, 2030. The award funds the Implementation Science Coordination Initiative (ISCI) at the Third Coast Center for AIDS Research to serve as a national coordination, consultation, and...
- Federal Project Grant Summary Northwestern University's Sponsored Research Division received a $106,922 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded February 26, 2026, with completion scheduled for October 31, 2028. The award supports investigator-initiated research focused on understanding the biological mechanisms governing food allergen absorption and anaphylaxis risk. The...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 project grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on September 3, 2025, with completion scheduled for August 31, 2027. The award supports research to characterize HIV-1 viral reservoirs and identify cellular sources and genetic diversity of persistent viral populations in antiretroviral...
- Federal Grant Award Summary The University of Chicago received a $807,799 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 15, 2025, with a completion date of June 30, 2030. This award funds research to identify and characterize B cell-dependent regulatory T (Treg) cells, a specialized subset of immune regulatory cells that directly control self-reactive B cells and...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $240,000 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 5, 2025, through August 31, 2027. The grant funds research investigating bile resistance mechanisms in Pseudomonas aeruginosa (PA), a leading cause of healthcare-associated infections responsible for over...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Chicago a Project Grant of $3,018,216 under the Allergy and Infectious Diseases Research program (CFDA 93.855) on July 8, 2025, with a completion date of June 30, 2029. This research project investigates the contributions of BRWD1-mediated cohesin conversion to B cell biology, focusing on how genomic mechanisms of diversity are coordinated with proliferation and...
- Federal Grant Award Summary The University of Chicago received a Project Grant award of $108,512 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 25, 2025, with a completion date of March 31, 2029. This award supports research investigating the developmental acquisition and functional characteristics of memory-phenotype CD8+ T cells in the context of infection and cancer. The research...
Northwestern University's Sponsored Research Division received a $739,353 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026, through January 31, 2031. The award supports fundamental research investigating the structural and molecular mechanisms of Store-Operated Calcium Release-Activated Calcium (CRAC) channels, which are critical regulators of cellular calcium signaling in immune cells and neuroglial cells. The research employs a multidisciplinary approach integrating photocrosslinking techniques using unnatural amino acids, cryo-electron microscopy structural analysis, and fluorinated phenylalanine analogs to elucidate the binding interface between Orai1 and Stim1 proteins and to characterize the gating mechanisms of Orai1 channels. The primary deliverables include determination of the molecular and structural basis of Orai1-Stim1 binding interactions and structural characterization of gain-of-function Orai mutants, including variants associated with human disease. This basic science research addresses gaps in understanding CRAC channel regulation, with potential implications for therapeutic development targeting diseases ranging from immunodeficiency to allergic disorders. The research will be conducted at Northwestern University's Chicago, Illinois facility and is structured to advance fundamental knowledge of calcium signaling mechanisms essential to immune cell function and disease pathogenesis.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $739.4k | 1/30/26 |